Behavioural and Cognitive Psychotherapy · 2013 · 39 citations · 29 references
MedicinePharmacotherapyPsychiatryBehavioral HealthOutcomes ResearchPsychopharmacologyAntidepressant TherapyClinical TrialsDepressive DisordersMental HealthPsychosocial InterventionsTreatment Of Mental DisordersAntidepressant EfficacyDepression Severity MeasurementDepression Symptom AssessmentDepressive Symptom AssessmentGroup InterventionGroup Therapy For DepressionOutcome MeasuresPsychosocial Treatment
BACKGROUND: Research in the West shows that group psychological intervention together with an antidepressant treatment leads to more effective treatment of a depressive disorder. There are no treatment trials from low income countries comparing the efficacy of antidepressant treatment with a group psychological intervention. AIM: To conduct a feasibility trial to compare the efficacy of an antidepressant to a group psychosocial intervention, for low income women attending primary health care in Karachi, Pakistan. METHOD: This was a preliminary RCT in an urban primary health care clinic in Karachi, Pakistan. Consecutive eligible women scoring >12 on the CIS-R and >18 on Hamilton Depression Rating Scale (HDRS) (n = 66) were randomly assigned to antidepressants or a psychosocial treatment in group settings. The primary outcome measure was HDRS score; secondary outcome measures were disability and quality of life. RESULTS: More than half of the patients in both groups improved (50% reduction in HDRS scores); at end of therapy at 3 months 19 (59.4%) vs 18 (56.2%), and at 6-month follow-up 21(67.7%) vs 20(62.5%) for antidepressants and psychosocial intervention respectively. Although HDRS, BDQ and EQ5-D scores all improved considerably in both groups from start to end of treatment, and these improvements were largely maintained after a further 3 months, the differences between the two treatments were not statistically significant. CONCLUSION: Psychosocial intervention was as effective as antidepressants in reducing depression and in improving quality of life and disability at the end of therapy. However, these findings need further exploration through a larger trial.
29
The MOS 36-ltem Short-Form Health Survey (SF-36)
John E. Ware, Cathy D. Sherbourne · Medical Care · 1992 · 29.8K citations
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Colin Mathers, Dejan Lončar · PLoS Medicine · 2006 · 11.5K citations · Full text
Disease control priorities in developing countries
Choice Reviews Online · 2006 · 3.6K citations
Public Affairs, Health Policy, Infectious Disease Control +9